Mingfang (Ming) Chen

Mingfang (Ming) Chen has a diverse work experience spanning over two decades. Mingfang (Ming) started as a Postdoctoral Fellow at the Department of Chemistry, University of Wyoming in 1993, where they worked until 1995. Mingfang (Ming) then moved to the Marine Pharmacology & Biotechnology Laboratories at the University of Rhode Island, where they served as a Postdoctoral Fellow for a year. From 1996 to 1997, they worked as a Postdoctoral Fellow at the Department of Chemistry, University of Wyoming.

In 1997, Ming joined Lorus Therapeutics Inc. as an R&D Chemist and worked there until 1999. Mingfang (Ming) then joined TorPharm Inc., a division of Apotex Group Companies, as a Senior R&D Analyst from 1999 to 2002. Ming continued their scientific career as a Principal Scientist at Inotek Pharmaceuticals Corporation from 2002 to 2005, and later transitioned to the role of a Senior Scientist until 2008.

In 2008, Ming joined Biogen as a Scientist II in Quality Control and worked there for four years until 2012. Mingfang (Ming) then joined Fibrogen Inc as Manager of QC Compliance in 2014 and stayed with the company until 2015. Mingfang (Ming)'snext role was as a Senior Manager of QC Compliance and Quality Assurance at Intarcia Therapeutics, Inc., where they worked from 2015 to 2017. Mingfang (Ming) then moved on to the role of Associate Director of Commercial QC at the same company in August 2017.

Mingfang (Ming) Chen has a Ph.D. in Organic Chemistry from the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China. Prior to that, Ming also earned a Master of Science (M.Sc.) degree in Analytical Chemistry from the same institution. There is no information available regarding the start and end years for these degrees. Additionally, Ming Chen has some association with William George Associates, although no specific degree or field of study is provided for this experience.